When selecting a few of the new items, we first spoke to Gary Scheiner, MS, CDE, scientific director of Integrated Diabetes Services of Wynnewood, Pennsylvania. Scheiner, called the MacGyver of diabetes items, has dealt with Type 1 diabetes for more than 30 years. He tries brand-new items before recommending them to patients. “It’s important to see brand-new products from the user’s perspective, not simply from the [health-care practitioner’s] side of things,” stated Scheiner.
New Diabetes Devices 2017
In 2016, the speed of innovation continued to race ahead with incredible innovation right out of a Star Trek episode. The growing use of smartphone innovation and mobile applications has resulted in much better access to blood glucose readings, general health details, and far more. Keep reading to discover the most recent products. We guarantee you there’s something here for everyone, whether you deal with Type 1 or Type 2 diabetes.
In this installation, we take a look at glucometers and CGMs that have actually recently struck the marketplace.
Glucometers and CGMs
With the FDA’s approval of Medtronic’s MiniMed 670G, people with Type 1 diabetes will have the alternative of the first hybrid closed-loop insulin pump and continuous glucose monitoring system. Inning accordance with study outcomes, the MiniMed 670G will minimize time at unsafe low and high blood sugar levels, enhance time in variety, decrease glucose variability, bring much greater nighttime safety, and target morning blood glucose.
“The 670G is not a ‘cure’ and still requires some effort by users, but it is a really welcome advance that will make insulin therapy much safer and easier for many individuals with diabetes,” said Hooman Hakami, executive vice president and group president of Medtronic Diabetes.
The 670G is an upgrade from the MiniMed 630G system that was launched in August. Utilizing technology dubbed SmartGuard HCL, the system immediately changes the delivery of long-acting or basal insulin based on the user’s glucose reading. It allows greater glucose control and minimized user input. The system delivers a variable rate of insulin 24 hours a day based upon the customized needs of the individual, maximizing the time glucose levels are within the target variety. It is designed to “discover” an individual’s insulin needs and do something about it to lessen both low and high glucose levels. As a result, the system needs minimal input — users just need to enter mealtime carbs, accept bolus correction recommendations, and occasionally adjust the sensor.
Also read: Glucose meters (glucometers)
The MiniMed 670G consists of an insulin pump (with tubing), a constant glucose tracking sensor placed under the skin, and a transmitter worn on the body. When the 670G is operating in automobile mode, it gets a glucose value from the sensor.
Ascensia Diabetes Care included two new meters to its Contour family of glucometers. The Contour Next Link and Contour Next One were introduced last year. While the Contour Next Link was created specifically to link to a Medtronic insulin pump, the Contour Next One is targeted at a wider group of users. It links by means of Bluetooth to the Contour Diabetes app, available on iOS and Android. On the app, users can log their diet and workout and track patterns in their blood glucose. They can send out information to a care provider as a PDF and gain insights about their diabetes based on the data they get.
“Today, less than two percent of people dealing with diabetes use a connected meter,” said Robert Schumm, head of Ascensia Diabetes Care US. “Contour Next One is developed to be basic to use and can meet the needs of a broad group of users.”
Besides sending out information to an app, a “smartLight” function permits feedback, tips, and alerts to be shown on the meter itself. In clinical trials, the meter returned 95% of results precise within 8.4 mg/dl of lab referral values. Ascensia is presently preparing to launch the meters in early 2017, although the apps are currently available from the iTunes and Google Play stores.
The Dario Smart Meter lets you test blood glucose levels in seconds straight on your smartphone. The pocket-sized glucose tracking system developed by LabStyle features a meter, test strips, and a real-time mobile app to help manage diabetes quickly and easily. Readily available since March 2016, Dario Smart Meter enables users to track their blood glucose levels, carb intake, and exercise activities. It likewise consists of special functions such as emergency situation hypoglycemia signals via text messaging. All the info is caught in a smartphone and can be quickly shared with health-care service providers, member of the family, and caretakers.
Abbott has introduced a constant glucose monitoring system, FreeStyle Libre Pro. The system was authorized last fall, and a customer version is presently under evaluation with the FDA.
See also: Blood Sugar Monitoring
The FreeStyle Libre Pro gets rid of the requirement for routine finger punctures by reading glucose levels through a little sensor. A health-care expert uses the sensing unit to the back of the patient’s arm. A self-adhesive pad holds the water-resistant and non reusable sensing unit in location for up to 14 days, requiring no patient interaction with the device and eliminating the need to draw blood with a finger stay with calibrate the sensor.
The sensing unit continuously determines glucose in interstitial fluid through a little (5 mm long, 0.4 mm large) filament that is placed just under the skin. It tapes glucose levels every 15 minutes, catching as much as 1,340 glucose results for as much as 14 days and offering the treating doctor with thorough information for a total glucose profile. After 14 days, the patient returns to the doctor’s office, where the doctor uses a FreeStyle Libre Pro reader to scan the sensor and download the 14 days’ worth of glucose results stored in the sensing unit — in just 5 seconds.
While the Dexcom G5 Mobile Continuous Glucose Monitoring System itself is not new, a current FDA-approved growth for the product is making headlines. In December 2016, the FDA OK’d use of the system to replace fingerstick blood glucose screening in individuals age 2 and over. Previously, the system had actually just been authorized for complementing fingerstick screening. Now, a user need carry out just two fingersticks a day to adjust the system.